My watch list
my.bionity.com  
Login  

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris and in New York.

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, provided more than a billion doses of vaccine in 2006, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines protecting against 20 infectious diseases. The Company's heritage, to create vaccines that protect life, dates back more than a century. Sanofi Pasteur is the largest company entirely dedicated to vaccines. Every day, the company invests more than EUR1 million in research and development.

One of the world's leading pharmaceutical companies and number 1 in Europe.

Our major therapeutic areas : Cardiovascular, thrombosis, metabolic disorders, oncology, central nervous system, internal medicine and vaccines.

About 100,000 employees worldwide. Sales force of 35,000 medical visitors.

Present in 100 countries throughout the 5 continents. Consolidated sales of 28 billion euros and more than 4 billion euros Research & Development.

5,3% Market share.

More about Sanofi-Aventis
  • News

    Sanofi and Luminostics to join forces on developing breakthrough COVID-19 smartphone-based self-testing solution

    Sanofi and Luminostics have signed an agreement to evaluate a collaboration on a unique self-testing solution for COVID-19, using Luminostics’ technology, and further adding to Sanofi’s ongoing efforts to fight the COVID-19 pandemic on multiple fronts.Luminostics would contribute its propri ... more

    Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19

    Sanofi and GSK announce that they have signed a letter of intent to develop an adjuvanted vaccine for COVID-19, using innovative technology from both companies, to help address the ongoing pandemic. Sanofi will contribute its S-protein COVID-19 antigen, which is based on recombinant DNA tec ... more

    Evotec receives € 3 million payment from Sanofi

    Evotec SE announced successful achievement of a third milestone in their diabetes research alliance with Sanofi (“TargetBCD”), resulting in a payment of € 3 m to Evotec. This milestone was triggered after Evotec met pre-agreed critical criteria within the beta cell replacement therapy progr ... more

  • Companies

    sanofi-aventis Groupe

    One of the world's leading pharmaceutical companies and number 1 in Europe. Sanofi-aventis' pharmaceuticals business focuses on six therapeutic areas: diabetes, oncology, thrombosis, cardiovascular diseases, central nervous system (CNS) and internal medicine. About 100,000 employees worl ... more

    Sanofi-Aventis Deutschland GmbH

    Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris and in New York. Sanofi Pasteur, the vaccines division of sanofi-aventis Group, provided more than a billi ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE